Journal
Oncogene
Publication Date
7-1-2023
Volume
42
Issue
29
First Page
2263
Last Page
2277
Document Type
Open Access Publication
DOI
10.1038/s41388-023-02747-x
Rights and Permissions
Sawant, M., Wilson, A., Sridaran, D. et al. Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor. Oncogene 42, 2263–2277 (2023). https://doi.org/10.1038/s41388-023-02747-x This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Sawant, Mithila; Wilson, Audrey; Sridaran, Dhivya; Mahajan, Kiran; O'Conor, Christopher J; Hagemann, Ian S; Luo, Jingqin; Weimholt, Cody; Li, Tiandao; Roa, Juan Carlos; Pandey, Akhilesh; Wu, Xinyan; and Mahajan, Nupam P, "Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor." Oncogene. 42, 29. 2263 - 2277. (2023).
https://digitalcommons.wustl.edu/oa_4/2161
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
